BEGONIA trial: durvalumab plus trastuzumab deruxtecan for HER2-low metastatic breast cancer
In one of oncology's most closely watched experiments, an antibody-drug conjugate paired with an immune checkpoint inhibitor has produced unusually ...
In one of oncology's most closely watched experiments, an antibody-drug conjugate paired with an immune checkpoint inhibitor has produced unusually ...
A routine photograph of the back of the eye has quietly become one of the most information-dense objects in modern ...
In the race to harness artificial intelligence for discovering better catalysts, a sobering new study has emerged that quantifies just ...
Beneath every square centimeter of the human small intestine lies a hidden scaffold of cells that has quietly governed one ...
One of the oldest puzzles in evolutionary biology has just received what may be its most complete genomic answer: why ...
For two decades, neuroscientists have been building ever finer maps of gene activity in the brain, charting which genes switch ...
Pancreatic cancer has earned its grim reputation the hard way. Fewer than one in eight patients survives five years beyond ...
For decades, chemists working on electronic materials have treated molecular decomposition as the enemy—a process to be suppressed with every ...
Tuberculosis has quietly reclaimed a title no pathogen should want: the world's deadliest infectious disease. According to the World Health ...
Long before lupus announces itself with swollen joints and damaged kidneys, long before type 1 diabetes destroys enough insulin-producing cells ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine